Home › Funds › Birch Hill Investment Advisors LLC › WST

Birch Hill Investment Advisors LLC position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

Birch Hill Investment Advisors LLC reported holding 158,911 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$58.9M, representing 2.42% of its reported portfolio and ranking #16 among its reported holdings. Birch Hill Investment Advisors LLC has disclosed WST holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)158.91K sh
Reported value held$58.92M
Portfolio Weight2.42%
First reportedQ2 2025
Last changeHold
Updated2026-10-16

Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR

How Birch Hill Investment Advisors LLC's WST position evolved

Birch Hill Investment Advisors LLC first disclosed a stake in WST in Q2 2025 at 72,832 shares (US$15.9M). The position peaked in Q3 2026 at 158,911 shares, worth US$58.9M. Across 6 filings, Birch Hill Investment Advisors LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 158,911 shares valued at US$58.9M. Notable position changes include a 87% increase in Q3 2025 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 72.83K $15.94M New
Q3 2025 136.47K $35.80M Add
Q4 2025 152.15K $41.86M Add
Q1 2026 161.16K $40.39M Add
Q2 2026 159.70K $57.33M Reduce
Q3 2026 158.91K $58.92M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 35 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$865.8M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has Birch Hill Investment Advisors LLC held WST?

Birch Hill Investment Advisors LLC has disclosed WST holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Birch Hill Investment Advisors LLC's current position in WST?

As of Q3 2026, Birch Hill Investment Advisors LLC holds 158.91K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $58.92M, representing 2.42% of its reported portfolio and ranking #16.

Has Birch Hill Investment Advisors LLC been buying or selling WST?

In the latest 13F filing (Q3 2026), Birch Hill Investment Advisors LLC held unchanged its position in WST. The position peaked in Q3 2026 at 158.91K shares.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.